In a research report released Tuesday, Oppenheimer analyst Steven Lichtman maintained an Outperform rating on Sunshine Heart Inc (NASDAQ:SSH) and reduced the price …
In a research report released today, Canaccord analyst Jason Mills reiterated a Buy rating on shares of Sunshine Heart Inc (NASDAQ:SSH), but reduced the price …
Sunshine Heart Inc (NASDAQ:SSH) announced its financial results and provided a corporate update for the second quarter of 2015. The Company will host a …
Sunshine Heart Inc (NASDAQ:SSH) announced an update on its next generation, fully implantable version of the Company’s flagship C-Pulse® technology. Sunshine Heart is pleased …
Sunshine Heart, Inc. (NASDAQ:SSH) announced an update on its COUNTER HF™ US pivotal study for the C-Pulse Heart Assist System.
Sunshine Heart Inc (NASDAQ:SSH), announced that on July 20, 2015, the Compensation Committee of its Board of Directors, which is composed entirely of independent …
Sunshine Heart Inc (NASDAQ:SSH) announced that it has exercised the right to borrow an additional $2 million under its existing loan and security agreement …
Company Overview From the Sunshine Heart Inc (NASDAQ:SSH) website – The C-Pulse Heart Assist System leverages the known concept of counterpulsation. The …
Sunshine Heart, Inc. (NASDAQ:SSH) is pleased to announce that the US Food and Drug Administration (FDA) has approved the resumption of patient enrollment …
Canaccord’s healthcare analyst Jason Mills weighed in with an optimistic view on Sunshine Heart Inc (NASDAQ:SSH), following the news that the FDA responded to the company’s IDE …
